GlassScriptPhysician profile
Donald Foster
NPI 1811363286
$7,419.27
in general payments reported to CMS, 2019-2025
20 companies · $990 in 2025
The $990 reported for 2025 was more than what 87% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
See the full distribution for Acute Care (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,217 · 2022: $1,151 · 2023: $2,008 · 2024: $2,052 · 2025: $990.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,849 · Travel and Lodging: $202.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,848.76 |
| Travel and Lodging | $201.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $5,607.83 | 2021-2025 | Cardiomems, Thoratec Heartmate 3 Lvas Implant Kit, Confirm Rx |
| Boston Scientific Corporation | $195.60 | 2024-2025 | Watchman Access System, Bodyguardian, Watchman Flx |
| Edwards Lifesciences Corporation | $189.66 | 2024-2025 | Sapien 3 Ultra Resilia |
| Impulse Dynamics (USA) INC. | $171.00 | 2023 | Optimizer |
| Merck Sharp & Dohme LLC | $159.84 | 2023-2025 | Verquvo |
| Novartis Pharmaceuticals Corporation | $158.89 | 2024-2025 | |
| Esperion Therapeutics, INC. | $151.79 | 2022-2024 | Nexletol |
| Amgen INC. | $138.16 | 2023-2025 | Repatha, Repatha |
| Alexion Pharmaceuticals, INC. | $124.40 | 2021 | |
| Medtronic, INC. | $115.48 | 2023-2024 | Endurant Iis, Onyx Frontier |
| Actelion Pharmaceuticals US, INC. | $95.82 | 2022 | |
| Janssen Pharmaceuticals, INC | $83.63 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $49.35 | 2024 | Wainua |
| Kiniksa Pharmaceuticals International, Plc | $40.86 | 2024 | Arcalyst |
| Lexicon Pharmaceuticals, INC. | $32.16 | 2024 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alnylam Pharmaceuticals INC. | $26.45 | 2023 | Onpattro |
| Regeneron Healthcare Solutions, INC. | $22.32 | 2024 | Evkeeza |
| Tactile Systems Technology INC | $22.12 | 2024 | Entre Plus, Flexitouch Plus |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $18.30 | 2025 | Lifevest |
| Biosense Webster, INC. | $15.61 | 2023 | Carto 3 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Donald Foster listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.